RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-2.86%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.33B
AUM Growth
+$4.33B
(-9%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
30.21%
Holding
157
New
4
Increased
81
Reduced
15
Closed
21
Top Buys
| 1 |
Baxter International
BAX
|
$24.4M |
| 2 |
Xilio Therapeutics
XLO
|
$19.1M |
| 3 |
Aura Biosciences
AURA
|
$17.1M |
| 4 |
Compass Therapeutics
CMPX
|
$16.9M |
| 5 |
Agilon Health
AGL
|
$11.3M |
Top Sells
| 1 |
Teleflex
TFX
|
$49M |
| 2 |
ALLK
Allakos
ALLK
|
$32.4M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$26.3M |
| 4 |
Bolt Biotherapeutics
BOLT
|
$20.9M |
| 5 |
OSH
Oak Street Health, Inc.
OSH
|
$18.8M |
Sector Composition
| 1 | Healthcare | 94.68% |
| 2 | Consumer Staples | 1.28% |
| 3 | Industrials | 0.73% |
| 4 | Financials | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
26
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $55.9M | 1.29% |
426,843
+34,926
| +9% | +$4.58M |
|
27
Freshpet
FRPT
$2.59B
| $55.3M | 1.28% |
580,000
+53,000
| +10% | +$5.05M |
|
28
Ascendis Pharma
ASND
$12.1B
| $53.8M | 1.24% |
400,000
| – | – |
|
|
CERE
29
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $53.4M | 1.23% |
1,648,435
+47,846
| +3% | +$1.55M |
|
30
iRhythm Technologies
IRTC
$5.67B
| $51M | 1.18% |
433,000
-15,000
| -3% | -$1.77M |
|
31
Kymera Therapeutics
KYMR
$3.1B
| $47.1M | 1.09% |
742,065
+9,138
| +1% | +$580K |
|
32
Acadia Healthcare
ACHC
$2.15B
| $45.4M | 1.05% |
748,500
+38,500
| +5% | +$2.34M |
|
33
Exact Sciences
EXAS
$9.33B
| $44.4M | 1.03% |
570,000
| – | – |
|
|
NVTA
34
DELISTED
Invitae Corporation
NVTA
| $42.8M | 0.99% |
2,800,243
+194,414
| +7% | +$2.97M |
|
35
Penumbra
PEN
$10.5B
| $42.7M | 0.99% |
148,500
+1,000
| +0.7% | +$287K |
|
|
SWAV
36
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $39.7M | 0.92% |
222,500
+2,500
| +1% | +$446K |
|
|
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
| $39.6M | 0.91% |
256,000
+6,000
| +2% | +$928K |
|
38
Sarepta Therapeutics
SRPT
$1.98B
| $38.2M | 0.88% |
424,000
+74,000
| +21% | +$6.66M |
|
39
Arvinas
ARVN
$580M
| $37.6M | 0.87% |
457,200
-120,300
| -21% | -$9.88M |
|
40
Warby Parker
WRBY
$3.08B
| $33.7M | 0.78% |
724,000
+74,000
| +11% | +$3.45M |
|
41
Health Catalyst
HCAT
$228M
| $33.7M | 0.78% |
850,200
+200
| +0% | +$7.92K |
|
|
VERV
42
DELISTED
Verve Therapeutics
VERV
| $33.3M | 0.77% |
902,926
-59,900
| -6% | -$2.21M |
|
|
CVET
43
DELISTED
Covetrus, Inc. Common Stock
CVET
| $33.2M | 0.77% |
1,661,700
+38,200
| +2% | +$763K |
|
44
Encompass Health
EHC
$12.5B
| $32.8M | 0.76% |
502,500
+2,500
| +0.5% | +$163K |
|
45
Phreesia
PHR
$1.81B
| $32.1M | 0.74% |
770,000
-200,000
| -21% | -$8.33M |
|
46
Prothena Corp
PRTA
$452M
| $32M | 0.74% |
647,730
-62,700
| -9% | -$3.1M |
|
|
ACCD
47
DELISTED
Accolade, Inc. Common Stock
ACCD
| $31.6M | 0.73% |
1,197,000
+274,000
| +30% | +$7.22M |
|
48
DexCom
DXCM
$30.9B
| $30.5M | 0.7% |
56,750
+10,250
| +22% | +$5.5M |
|
49
Travere Therapeutics
TVTX
$1.75B
| $29.5M | 0.68% |
951,650
-545,167
| -36% | -$16.9M |
|
|
ABCM
50
DELISTED
Abcam plc American Depositary Shares
ABCM
| $29.5M | 0.68% |
1,252,500
+104,912
| +9% | +$2.47M |
|